Genomic characterisation of acral melanoma cell lines
Simon J. Furney(King's College London), Richard Marais(Macclesfield College), Meenhard Herlyn(The Wistar Institute), Iwanka Kozarewa(AstraZeneca (United Kingdom)), Samra Turajlic(Royal Marsden NHS Foundation Trust), Hiroshi Murata(Shinshu University), Alan Ashworth(University of California, San Francisco), Costas Mitsopoulos(Institute of Cancer Research), Alan Mackay(Institute of Cancer Research), Gerda Ricken(Medical University of Vienna), Christopher J. Lord(Institute of Cancer Research), Kerry Fenwick(Institute of Cancer Research), J. S. Reis-Filho(Universidade do Porto), Jarle Hakas(Institute of Cancer Research), Maryou Lambros(Institute of Cancer Research), Marketa Zvelebil(Institute of Cancer Research)
Cited by 50
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k